News & Updates
Filter by Specialty:
Early intubation tied to better survival in COVID-19 patients with ARDS
Late intubation compounds the risk of death among coronavirus disease 2019 (COVID-19) patients on mechanical intubation due to respiratory insufficiency, a recent study has found.
Early intubation tied to better survival in COVID-19 patients with ARDS
11 Oct 2021Kidney stone disease prevalent among people with disabilities
Nephrolithiasis appears to be common among people with disabilities (PWDs), such that one in three people who have the kidney stone disease is a PWD, as reported in a study from the US.
Kidney stone disease prevalent among people with disabilities
10 Oct 2021Blood coagulation profile in pregnant women with severe anaemia linked to postpartum bleeding
Altered measures of the coagulation parameters, specifically high international normalised ratio and low haemoglobin, in the third trimester of pregnancy among women with severe anaemia appear to contribute to an increased risk of postpartum haemorrhage, a study has found.
Blood coagulation profile in pregnant women with severe anaemia linked to postpartum bleeding
10 Oct 2021Pseudopyloric metaplasia does not predict development of gastric cancer
Neither gastric cancer nor gastric dysplasia is seen in patients with corpus atrophic gastritis (CAG) characterized at baseline with corpus pseudopyloric metaplasia (PPM) without corpus intestinal metaplasia (IM) because such lesions are consistently associated with corpus IM, reports a study.
Pseudopyloric metaplasia does not predict development of gastric cancer
10 Oct 2021Antimigraine drugs may complicate pregnancy
The antimigraine medications dihydroergotamine (DHE) and triptan seem to aggravate the risk of adverse pregnancy outcomes such as premature birth and spontaneous abortion (SA), a recent study has found.
Antimigraine drugs may complicate pregnancy
10 Oct 2021ACE inhibitors, ARBs put brakes on emphysema progression, lung function decline in COPD
Angiotensin converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) appear to be beneficial to chronic obstructive pulmonary disease (COPD) patients, with a recent study suggesting that the use of such drugs may slow down progression of emphysema and lung function decline.